NASDAQ: ITCI - Intra-Cellular Therapies, Inc.
半年間の収益性: +63.06%
配当利回り: 0.00%
セクタ: Healthcare
半年間の収益性: +63.06%
配当利回り: 0.00%
セクタ: Healthcare